NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,023 Cr | ₹1,477 Cr | ₹1,559 Cr | ₹1,191 Cr | ₹951 Cr |
What is the latest Revenue of NEULAND LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,023 Cr |
| Mar2025 | ₹1,477 Cr |
| Mar2024 | ₹1,559 Cr |
| Mar2023 | ₹1,191 Cr |
| Mar2022 | ₹951 Cr |
How is Revenue of NEULAND LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,023 Cr | 36.98 | |
| Mar2025 | ₹1,477 Cr | -5.24 | |
| Mar2024 | ₹1,559 Cr | 30.84 | |
| Mar2023 | ₹1,191 Cr | 25.25 | |
| Mar2022 | ₹951 Cr | - | |
Compare Revenue of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹27,675.3 Cr | 6.4% | 8.4% | 22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 6.4% |
8.4% |
22.6% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses